December 5, 2023
National Institute on Drug Abuse (NIDA)
This notice informs applicants of a change to the PHS 398 Research Plan for PAR-23-194: Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed).
Part 2. Full Text of Announcement
Section IV. Application and Submission Information
PHS 398 Research Plan
Other Plan(s):
Note: Effective for due dates on or after January 25, 2023, the Data Management and Sharing Plan will be attached in the Other Plan(s) attachment in FORMS-H application forms packages.
All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:
Currently, reads:
Not Applicable
Revised to read (changes noted in bold italics):
All other aspects of this PAR remain the same.
Marsha F. Lopez, Ph.D., M.H.S.
National Institute on Drug Abuse (NIDA)
Phone: 301-443-6504
Email: [email protected]
Keisher Highsmith, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-402-1984
Email: [email protected]
Guifang Lao, M.D., Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-827-5931
Email: [email protected]
Beth Babecki, M.A.
National Institute on Drug Abuse (NIDA)
Phone: 301-435-0899
Email: [email protected]
Lindsey Friend, Ph.D.
National Institute on Drug Abuse (NIDA)
Phone: 301-402-1428
Email: [email protected]